Corporate Crime In The Pharmaceutical Industry: Why We Must Be Concerned

Azlinda Abdul Samad, Abdul Samad Abdul Ghani

Abstract


The impact of corporate crime is wide and varies. This study intends to highlight on this, from the perspective of the pharmaceutical industry. This study is conducted by using a semi-structured interview question. Information is also collected from books, journals, reports, websites etc. The objective of this study is to determine the impacts of corporate crime in the pharmaceutical industry and provides some suggestion to overcome the issues. Corporate crime in the pharmaceutical industry is an issue of concern because of its impact, especially on public safety and health, as it may lead to serious cases of permanent disability and fatality. Additionally, it can lead to other serious issues including the diversion of prescription medicine for non-medical or illicit use. It may also hamper the nation with the issue of drug problems which will consequently, affect the family institution as well as the society at large. The health system may also be affected due to the unsafe use of medicinal products and unethical practices among health professionals and personnel. Consumers or patients may also be exposed to untruthful and inaccurate drug advertisements and information. The crime has a negative impact on the pharmaceutical company itself and may tarnish the country’s name and reputation. To overcome and stop corporate crime, requires cooperation and commitment from various entity. Holistic actions and approaches need to be taken to dealt with the issue immediately so it does not get worse.


Keywords


Corporate crime; pharmaceutical industry; public safety; unsafe medicines; drug advertisements

Full Text:

PDF

References


Alcadipani, R., & de Oliveira Medeiros, C. R. 2020. When corporations cause harm: A critical view of corporate social irresponsibility and corporate crimes. Journal of Business Ethics 167(2): 285-297.

Afolayan, M. S., & Oniyinde, O. A. 2019. Interviews and questionnaires as legal research instruments. JL Pol’y & Globalization 83: 51-59.

Anon. 2012. Highlights of Prescribing Information. United States Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021087s062lbl.pdf [30 August 2022].

Anon. 2018. 5 Doctors among 10 Arrested in New York City, Westchester Prescription Drug Bust. Eyewitness News ABC7. https://abc7ny.com/staten-island-new-yorkcity-oxycodone-drug-bust/4461710/ [15 August 2022].

Arnold, D. G., Amato, L. H., Troyer, J. L., & Stewart, O. J. 2022. Innovation and misconduct in the pharmaceutical industry. Journal of Business Research 144: 1052-1063.

Braithwaite, J. 2013. Corporate Crime in the Pharmaceutical Industry. London: Routledge & Kegan Paul. Braithwaite, J. 2020. Regulatory mix, collective efficacy, and crimes of the powerful. Journal of White Collar and Corporate Crime 1(1): 62-71.

Candra, S. 2020. Beneficial owner criminal liability for corporate crimes in the environment sector. International Journal of Research in Commerce and Management Studies 2(3):38-50.

Csorba, L. M. 2020. Drugs consumer protection - a socio-economic point of view regarding drugs safety. Economic Alternatives (2): 262-282.

Davis, C., & Abraham, J. 2013. Is there a cure for corporate crime in the drug industry? British Medical Journal 346 (f755) British Medical Journal.

Dworkin, S. L. 2012. Sample size policy for qualitative studies using in-depth interviews. Archives of Sexual Behavior 41: 1319-1320.

Fahim, M., & Kabir, H. 2021. Exploring the threats of corporate crime as a rising trend of white-collar crime in Bangladesh: An empirical study in the light of Criminal Law. Journal of Asia Pacific Studies 6(1):23-38.

Gøtzsche, P. C. 2012. Big pharma often commits corporate crime, and this must be stopped. British Medical Journal 345(e8462).

Gøtzsche, P. C. 2013. Deadly Medicines and Organised Crime: How Big Pharma has Corrupted Healthcare. New York: CRC Press.

Gupta, Y. K., Meenu, M., & Mohan, P. 2015. The Tamiflu fiasco and lessons learnt. Indian Journal of Pharmacology 47(1): 11-16.

Hussain, K., Patel, P., & Roberts, N. 2022. The role of thalidomide in dermatology. Clinical and Experimental Dermatology 47(4): 667-674.

Jefferson, T., Jones, M. A., Doshi, P., Del Mar, C. B., Hama, R., Thompson, M. J., & Heneghan, C. J. 2014. Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database of Systematic Reviews (4).

Laskai, A. 2020. Undue Pharmaceutical Industry Influence in Medical Profession. In Institutional Corruption Theory in Pharmaceutical Industry-Medicine Relationships. Springer, Cham 19: 17-48.

Luu, V. & Price, M. 2018. GlaxoSmithKline Health Care Fraud Settlement with the US Justice Department, 2012. Student Works. https://repositories.lib.utexas.edu/bitstream/handle/2152/74966/EthicsReport2018-converted.pdf?sequence=2 [13 December 2022].

McCarthy, E. 2019. A call to prosecute drug company fraud as organized crime. Syracuse L. Rev. 69(439): 439-488 Medicines (Advertisement and Sale) Act 1956 [Act 290].

MedicalNewsToday. 2019. What to Know About Paxil (Paroxetine). https://www.medicalnewstoday.com/articles/325996 [31 December 2022].

Mhatre, V., Vyas, L. K., & Bharati, D. K. 2022. Rebirth of thalidomide. World Journal of Pharmaceutical Research 11(7): 842-854.

Mulinari, S., & Ozieranski, P. 2022. Capitalizing on transparency: commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act. Big Data & Society 9(1):1-14.

National Anti-Drug Agency. 2023. Statistic trend of number of drug addicts detected according to type of drugs, 2016-2020. https://www.adk.gov.my/en/statistictrend-of-number-of-drug-addicts-detected-according-totype-of-drugs-2016-2020/ [23 January 2023].

National Anti-Drug Agency. 2023. Statistic trend of number of drug addicts detected according to reason of taking drugs, 2016 – 2020’, 2023, https://www.adk.gov.my/en/statistic-trend-of-number-of-drug-addictsdetected-according-to-reason-of-taking-drugs-2016-2020/ [23 January 2023].

Nevels, R. M., Gontkovsky, S. T., & Williams, B. E. 2016. Paroxetine-the antidepressant from hell? Probably not, but caution required. Psychopharmacology Bulletin 46(1): 77–104.

Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New England Journal of Medicine 360(25): 2605-2615.

Rumiartha, I. N. P. B., & Indradewi, A. A. S. N. 2020. The concept of consumer protection: An international cultural perspective. The International Journal of Language and Cultural (TIJOLAC) 2(02): 52-57.

Schneider, W. H. 2021. The Establishment of Institutional Review Boards in the US Background History. https://scholarworks.iupui.edu/bitstream/handle/1805/27399/Schneider_IRBHistory.pdf?sequence=2 [12 November 2022].

Shaari, S. C., Mahmod, N. A. K. N., & Baig, F. B. S. 2020. A non-doctrinal study on the implementation of occupational safety and health (OSH) legislation in manufacturing small and medium enterprises (SMEs) of Sabah. Asian Journal of Entrepreneurship 1(4): 11-26.

Sjoostrrom, H. & Nilsson, R. 1972. Thalidomide and the Power of the Drugs Company, England: Penguins Books Ltd.

The United States Department of Justice. 2012. GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data. https://www.justice.gov/opa/pr/glaxosmithkline-plead-guilty-and-pay-3-billion-resolvefraud-allegations-and-failure-report [13 December 2022].

Van Schaik, S. & Bonomi, A. 2019. Evaluation: From Policy to Practice. SUSTAINALYTICS. https://www.dr-rath-foundation.org/wp-content/uploads/2019/03/Evaluation-Report-From-Policy-to-Practice.pdf [10 December 2022].

Vilhelmsson, A., & Mulinari, S. 2020. Pharmaceutical lobbying and pandemic stockpiling: A feeling of dejavu in the Nordic countries and why the sociological perspective is crucial to understand COVID-19. Acta Sociologica 63(4): 439-442.

World Health Organization Regional Office for South-East Asia. 2009. Pandemic H1N1 2009 Report of Regional Consultation on Pandemic H1N1 2009 and Strengthening Country Capacity for Pandemic Preparedness. https://apps.who.i n t / i r i s / b i t s t r e a m / h a n d l e / 1 0 6 6 5 / 2 0 5 6 0 5 / B 4 3 9 9 .pdf?sequence=1&isAllowed=y [1 December 2022].

Yashiro, K., Miyagawa, S., & Sawa, Y. 2018. A lesson from the thalidomide tragedy - The past is never dead. It’s not even past. William Faulkner, from “Requiem for a Nun” Circulation Journal 82(9): 2250-2252.

Zabeen, I. A., & Zubaida Khatun, M. M. H. 2020. Comparative study on strategies for the prevention, diagnosis and treatment of birth defects. The Pharma Innovation Journal 9(2):72-80.


Refbacks

  • There are currently no refbacks.